DrugPatentWatch Database Preview
Zydus Pharms Company Profile
Email this page to a colleague
» See Plans and PricingWhat is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and three approved drugs.
There are nineteen tentative approvals on ZYDUS PHARMS drugs.
Summary for Zydus Pharms
| US Patents: | 0 |
| Tradenames: | 174 |
| Ingredients: | 173 |
| NDAs: | 203 |
Drugs and US Patents for Zydus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa Inc | GLIPIZIDE AND METFORMIN HYDROCHLORIDE | glipizide; metformin hydrochloride | TABLET;ORAL | 078905-002 | Jan 31, 2011 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 206641-006 | Aug 11, 2017 | AB4 | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms Usa | AMLODIPINE BESYLATE | amlodipine besylate | TABLET;ORAL | 078226-001 | Jul 9, 2007 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 206534-005 | Aug 8, 2017 | AB3 | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms Usa | RIBAVIRIN | ribavirin | CAPSULE;ORAL | 077224-001 | Oct 28, 2005 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 203293-001 | Aug 3, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Zydus Pharms Usa Inc | OMEPRAZOLE | omeprazole | CAPSULE, DELAYED REL PELLETS;ORAL | 091352-001 | Nov 19, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
